Nampt/PBEF/visfatin and cancer - PubMed
- ️Fri Jan 01 2010
Review
. 2010 Jul 15;10(2):119-25.
doi: 10.4161/cbt.10.2.12581. Epub 2010 Jul 3.
Affiliations
- PMID: 20647743
- DOI: 10.4161/cbt.10.2.12581
Free article
Review
Nampt/PBEF/visfatin and cancer
Tie-qiang Bi et al. Cancer Biol Ther. 2010.
Free article
Abstract
Nampt/PBEF/visfatin is the rate-limiting enzyme that catalyzes the first step in NAD biosynthesis from nicotinamide and regulates growth, apoptosis and angiogenesis of mammalian cells. This enzyme was originally cloned as a putative cytokine shown to enhance the B cell precursor maturation in the presence of IL-7 and stem cell factor. A number of cancers have increased expression of Nampt/PBEF/visfatin, which regulates a variety of different signaling pathways such as PI3K/Akt, ERK1/2 and STAT3. FK866/APO866 and CHS828/GMX1777 are two known inhibitors of Nampt/PBEF/visfatin and have been evaluated as anticancer agents in the clinic. This review will focus on its role in carcinogenesis and cancer progression and its inhibitors as therapeutic target for cancer treatment.
Similar articles
-
Jacques C, Holzenberger M, Mladenovic Z, Salvat C, Pecchi E, Berenbaum F, Gosset M. Jacques C, et al. J Biol Chem. 2012 Apr 27;287(18):15100-8. doi: 10.1074/jbc.M112.350215. Epub 2012 Mar 7. J Biol Chem. 2012. PMID: 22399297 Free PMC article.
-
Nampt/Visfatin/PBEF: a functionally multi-faceted protein with a pivotal role in malignant tumors.
Jieyu H, Chao T, Mengjun L, Shalong W, Xiaomei G, Jianfeng L, Zhihong L. Jieyu H, et al. Curr Pharm Des. 2012;18(37):6123-32. doi: 10.2174/138161212803582531. Curr Pharm Des. 2012. PMID: 22934941 Review.
-
Tan B, Dong S, Shepard RL, Kays L, Roth KD, Geeganage S, Kuo MS, Zhao G. Tan B, et al. J Biol Chem. 2015 Jun 19;290(25):15812-15824. doi: 10.1074/jbc.M114.632141. Epub 2015 May 5. J Biol Chem. 2015. PMID: 25944913 Free PMC article.
-
The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals.
Revollo JR, Grimm AA, Imai S. Revollo JR, et al. Curr Opin Gastroenterol. 2007 Mar;23(2):164-70. doi: 10.1097/MOG.0b013e32801b3c8f. Curr Opin Gastroenterol. 2007. PMID: 17268245 Review.
-
Roberts KJ, Cross A, Vasieva O, Moots RJ, Edwards SW. Roberts KJ, et al. J Leukoc Biol. 2013 Sep;94(3):481-92. doi: 10.1189/jlb.1012527. Epub 2013 Jun 26. J Leukoc Biol. 2013. PMID: 23804809
Cited by
-
Sawicka-Gutaj N, Waligórska-Stachura J, Andrusiewicz M, Biczysko M, Sowiński J, Skrobisz J, Ruchała M. Sawicka-Gutaj N, et al. Tumour Biol. 2015 Sep;36(10):7859-63. doi: 10.1007/s13277-015-3506-z. Epub 2015 May 7. Tumour Biol. 2015. PMID: 25946974 Free PMC article.
-
The NAD metabolome--a key determinant of cancer cell biology.
Chiarugi A, Dölle C, Felici R, Ziegler M. Chiarugi A, et al. Nat Rev Cancer. 2012 Nov;12(11):741-52. doi: 10.1038/nrc3340. Epub 2012 Sep 28. Nat Rev Cancer. 2012. PMID: 23018234 Review.
-
Is eNAMPT/visfatin a potential serum marker of papillary thyroid cancer?
Sawicka-Gutaj N, Ziółkowska P, Derwich A, Gut P, Czarnywojtek A, Kloska M, Ruchała M. Sawicka-Gutaj N, et al. Ther Adv Endocrinol Metab. 2022 Apr 13;13:20420188221090005. doi: 10.1177/20420188221090005. eCollection 2022. Ther Adv Endocrinol Metab. 2022. PMID: 35450096 Free PMC article.
-
Zhang G, Zhang L, Sun S, Chen M. Zhang G, et al. Front Mol Biosci. 2021 Dec 20;8:790804. doi: 10.3389/fmolb.2021.790804. eCollection 2021. Front Mol Biosci. 2021. PMID: 34988121 Free PMC article.
-
Nicotinamide phosphoribosyltransferase in malignancy: a review.
Shackelford RE, Mayhall K, Maxwell NM, Kandil E, Coppola D. Shackelford RE, et al. Genes Cancer. 2013 Nov;4(11-12):447-56. doi: 10.1177/1947601913507576. Genes Cancer. 2013. PMID: 24386506 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous